Sort
8,912 grants matching “sars cov 2”
Role of RNA modifications in coronaviruses replication
$8,109Marcos Morgan · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Molecular pathogenesis of human coronaviruses
$8,094Marshall Bloom · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Antibody responses to viruses
$7,906Christian Mayer · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
SARS-CoV2 infection in the intestine
$7,697Brian Kelsall · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Discovery of pseudoknots in the SARS-CoVID-2 RNA genome with SNP analysis
$7,605Philip C Bevilacqua · Pennsylvania State University, The · R35 · FY2020 · GM
Vaccinology During and After COVID-19
$7,500Terry L. Sheppard · Keystone Symposia · R13 · FY2023 · AI
Epidemiology, immunology, and evolution of SARS-CoV-2 and other coronaviruses before and during the COVID-19 pandemic
$7,446Leah Katzelnick · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Mechanism of Immune Dysfunction and Morbid Outcomes in Response to Shock/Sepsis
$7,057Alfred Ayala · Rhode Island Hospital · R35 · FY2024 · GM
Viral Infection and Inflammation Workshop 2024
$7,000Daniel R Kuritzkes · Brigham And Women'S Hospital · R13 · FY2024 · AI
SARS-CoV-2 Immunology and Therapeutics
$6,755Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
$6,500John S Lazo · Kevirx Inc. · R43 · FY2022 · HL
RespiDART 2022: Frontiers in Drug Development against Respiratory Viruses
$6,500Raymond F. Schinazi · Emory University · R13 · FY2023 · AI
Statistical Methods for Evaluation of Biomarkers
$6,465Aiyi Liu · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
2023 Chemical and Biological Defense GRC & GRS
$6,000Catherine S Branda · Gordon Research Conferences · R13 · FY2023 · AI
Tropical and Emerging Infectious Diseases for the Clinician and Translational Investigator
$6,000Peter C. Melby · University Of Texas Med Br Galveston · R13 · FY2024 · AI
T and B Cell Collaboration in Germinal Centers and Beyond
$5,500Terry L. Sheppard · Keystone Symposia · R13 · FY2023 · AI
Understanding how the MERS Coronavirus protein ORF4b interactions with importin alpha modulate innate immunity
$5,392Christopher F Basler · Georgia State University · R21 · FY2021 · AI
COVID Global Mix - Global Mix / Investigation of COVID-19 Disease Parameters for Transmission Models in Low-Resource Settings
$5,259Saad B. Omer · Ut Southwestern Medical Center · R01 · FY2025 · AI
Respi-DART: Frontiers in drug development against respiratory viruses and emerging viruses
$5,000Raymond F. Schinazi · Emory University · R13 · FY2025 · AI
2023 International Society for Vaccines (ISV) Annual Congress, October 22-25, Lausanne, Switzerland
$5,000David B. Weiner · International Society Of Vaccines · R13 · FY2023 · AI
The 2024 conference on "Epithelial mesenchymal interactions in lung development and fibrosis"
$5,000Stijn Piet Johan De Langhe · Mayo Clinic Rochester · R13 · FY2024 · HL
Fibrosis Pathogenesis and Resolution: From Mechanisms to Therapies
$5,000Terry L. Sheppard · Keystone Symposia · R13 · FY2023 · HL
Task B19: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses, SARS-CoV-2
$5,000Brett Hurst · Utah State University · N01 · FY2024 · AI
RespiDART & Emerging Viruses: Frontiers in Drug Development against Respiratory Viruses
$5,000Raymond F. Schinazi · Emory University · R13 · FY2021 · AI
Coronavirus antiviral nucleoside analogs: inhibition and reduced susceptibility
$4,919Maria Agostini · Vanderbilt University · F31 · FY2019 · AI